Search the hub
Showing results for tags 'Menopause'.
-
News Article
Misinformation about perimenopause on social media ‘putting women at risk’
Patient Safety Learning posted a news article in News
Misinformation about perimenopause is putting women at risk of unintended pregnancies, unnecessary medication and missed diagnoses, experts have said. Awareness of menopause and treatments such as hormone replacement therapy (HRT) has been raised by efforts including a prominent documentary by Davina McCall. But as a growing number of women encounter misleading information on social media, there are concerns that some could be led to false conclusions that can obscure real underlying health difficulties. “Everyone thinks they’re menopausal,” said Dr Paula Briggs, a consultant in sexual and reproductive health. “So we are seeing younger and younger women asking for HRT when what they need is hormonal contraception, as they’re still fertile. “I work in an abortion service and we’re seeing more women over 35 now who believe themselves to be menopausal and are gobsmacked when they become pregnant.” Briggs said misinformation around perimenopause is concerning. “I look at things like Instagram to see what they are exposed to and I am horrified,” she said, citing examples of women in their 30s being told to demand HRT if they are unable to sleep or are struggling with migraines – and to switch GPs if denied. Or women being told they should seek testosterone treatment. “I’m not anti any of these things in the right person, but females produce their own testosterone lifelong, even women without ovaries, so the idea that everybody has to demand testosterone is bonkers,” Briggs said. Dr Channa Jayasena, an expert in reproductive endocrinology at Imperial College London, also raised concerns. “It’s great that there’s better [public] awareness [about perimenopause]. And I think many doctors are completely unaware about how debilitating the symptoms of perimenopause can be,” he said. “But the flipside of that, I think there’s a risk that some women are being mislabelled as having perimenopause when they have other things that are wrong.” Read full story Source: The Guardian, 25 May 2026- Posted
-
- Information sharing
- Social media
-
(and 2 more)
Tagged with:
-
News Article
One of the biggest producers of hormone replacement therapy has been censured by regulators for “systemic failures” that jeopardised patient safety. Theramex, the UK producer of HRT drugs Evorel and Intrarosa, was found to have breached fundamental compliance standards including not updating crucial prescribing information – in some cases for several years – and not making it clear that a drug must not be used during pregnancy. The Prescription Medicines Code of Practice Authority (PMCPA), the UK drug industry’s self-regulatory body, issued the public reprimand against Theramex after its own staff blew the whistle over “alarming” compliance issues and incomplete prescribing information for Evorel and Intrarosa that “jeopardise patient safety”. Evorel patches – which contain estradiol – are among the most prescribed form of transdermal HRT, with more than 250,000 items issued in the last financial year, according to NHS Business Services Authority figures. Overall, nearly 10m items of estradiol, including gels, were prescribed in the 2024/25 financial year. The employees’ concerns included failing to provide comprehensive side-effect information in Evorel’s prescribing information, and not updating Intrarosa’s product information since 2019. The PMCPA also reprimanded the company for failures to specify in its advertising at a reproduction and advertising conference that Yselty (linzagolix), used to treat uterine fibroids, should not be taken during pregnancy. In all, PMCPA found that Theramex breached the Association of the British Pharmaceutical Industry (ABPI)’s code of practice 21 times. The panel said these breaches not only jeopardised patient safety, but that Theramex has “brought discredit upon, and reduced confidence in, the pharmaceutical industry”. Read full story Source: The Guardian, 22 April 2026- Posted
-
- Womens health
- Menopause
- (and 4 more)
-
News Article
Majority of women unaware menopause can trigger new mental illness
Patient Safety Learning posted a news article in News
Four in five adults do not know menopause can trigger a new mental illness, a poll has revealed. A YouGov poll, commissioned by the Royal College of Psychiatrists to highlight the lack of awareness and stigma associated with the menopause, also revealed that only 21% of adult women in the UK know a new mental illness can be linked to the menopause. That’s in comparison to 81% of people associating the menopause with hot flushes, 74% with mood changes and 64% with a reduced sex drive. Just over one in four women (28%) said they feel comfortable speaking to a male boss about menopause. This lack of knowledge has meant many women are not seeking or receiving the vital help they need. Royal College of Psychiatrists president Dr Lade Smith said: “Menopause can have a significant yet often overlooked impact on women’s mental health and wellbeing. Women account for 51 per cent of the population, and all will experience menopause at some point. This is a societal issue for everyone. Simply put, we must do better.” Read full story Source: The Independent, 2 March 2026 Further reading on the hub: Menopause and mental health: Implications for clinical practice, services and policy (RCPYSCH, March 2026) “It’s not menopause, you’re too young and don’t have the right symptoms"—the difficulties accessing menopause support and treatment Raising awareness of surgical menopause- Posted
-
- Menopause
- Womens health
-
(and 2 more)
Tagged with:
-
Content Article
This Royal College of Psychiatrists position statement examines how menopause affects mental health and its implications for clinical practice, services, and policy across the UK. Drawing on lived experience, clinical evidence and an intersectional approach, it highlights that menopause can significantly impact mental health and wellbeing, and is associated with anxiety, depression, cognitive changes and, sometimes, triggering or worsening serious mental illness. These effects are not experienced equally: people with severe mental illness, neurodivergence, minority ethnic backgrounds, LGBTQ+ identities, disabilities, or trauma histories often face greater barriers to care and poorer outcomes. Workplace impacts are also considerable, and gaps in clinical understanding, diagnostic overshadowing, limited access to HRT, and insufficient training across the mental health workforce further hinder effective support. This statement calls for: Greater awareness of menopause’s links to mental health Better training for psychiatrists and the wider workforce Fair access to diagnosis, treatment (including HRT) and mental health support The relationship between menopause and mental health to be fully integrated into the development and implementation of national women's health strategies Stronger, more supportive workplace policies Increased research across the board, and especially for under-represented groups Without proper support, many women struggle unnecessarily during the time of menopause transition. This statement outlines how healthcare, policy and workplaces can better respond to ensure compassionate, equitable and evidence-based care.- Posted
-
- Menopause
- Womens health
-
(and 2 more)
Tagged with:
-
News Article
The Food & Drug Administration (FDA) will remove broad “black box” warning labels from hormone replacement therapy (HRT) for menopause. The action, announced Monday, follows a comprehensive review of scientific literature by an expert panel at the agency in July, officials said, as well as a public comment period. Manufacturers are now expected to update and reprint their product labeling to remove references to risks of cardiovascular disease, breast cancer and probable dementia. “The label was designed to frighten women and to silence doctors,” Health and Human Services Secretary Robert F. Kennedy Jr. said on stage during the announcement on Monday morning. “The consequences have been devastating.” The FDA will not remove the boxed warning for endometrial cancer for systemic estrogen-only products. Its labeled recommendation will be to start HRT within 10 years of menopause onset or before 60 years of age for systemic HRT. Use of hormone replacement therapy (HRT) plummeted quickly after a flawed, now infamous 2002 study. While the study found a small increased risk of breast cancer among participants using HRT, described as less than a tenth of 1% per year for an individual woman, critics say its results were widely misinterpreted and blown out of proportion. A 2024 study found that only 5% of American women use HRT for menopause. About 80% of women experience menopause symptoms that can last years, yet research has found women who initiate HRT before the age of 60 have a reduction in all-cause mortality. HRT may also reduce the risk of cardiovascular disease by up to 50%; Alzheimer’s disease by 35%; bone fractures by up to 60%, according to figures an HHS press release cited. Echoing Kennedy, FDA Commissioner Marty Makary blamed the study and “medical group-think” for creating “a fear machine that still lingers.” No clinical trial has ever shown that HRT increases the risk of breast cancer mortality, said Makary, who was previously a surgical oncologist at Johns Hopkins. “How could the medical establishment get it so wrong for so long?” Makary questioned. “Women deserve the same rigorous science as do men.” Read full story Source: Fierce Healthcare, 10 November 2025 -
News Article
Surgical menopause like a 'hormonal cliff edge'
Patient Safety Learning posted a news article in News
A woman from East Sussex who was plunged into sudden menopause after surgery to remove both ovaries is spearheading efforts to change NHS policy in this area. Kate Dyson, 44, from Hastings, underwent the surgery six months ago after having a subtotal hysterectomy just over four years ago to remove her uterus - a procedure which leaves the cervix in place. The mum-of-three says she was completely unprepared for the impact of surgical menopause, which is triggered by both ovaries being removed. "Honestly it was like falling off a hormonal cliff edge," she told BBC Radio Sussex. "Within hours of the surgery I was home the same day. I was experiencing hot flushes, confusion, and the first night I woke up in the morning and I was absolutely dripping with sweat," she said. Ms Dyson says she found the aftercare galling, and says this is commonplace for many women. She said: "We are discharged without hormones, without warning, and without support. In my discharge notes it simply read, 'can try combined HRT [hormone replacement therapy] if she wishes', as if it were suggesting a glass of wine at the weekend." This experience prompted her to start campaign group Surge Menopause, whose aim is to push the Department of Health and Social Care (DHSC) to revolutionise its offering. Read full story Source: BBC News, 10 November 2025 Related reading on the hub: “It’s not menopause, you’re too young and don’t have the right symptoms"—the difficulties accessing menopause support and treatment Raising awareness of surgical menopause -
News Article
Government announces Women's Health Strategy to be renewed
Patient Safety Learning posted a news article in News
Women across the country will soon benefit from better and more compassionate care as the Women’s Health Strategy is set to be renewed to address longstanding barriers, the government has announced. This follows the announcement that menopause questions will be included in the NHS Health Check to better support millions of women. The renewed strategy will set out how the government will take the next steps to improve women’s healthcare as part of the 10 Year Health Plan and create a system that listens to women’s experiences and tackles the inequalities they face. As part of the renewal, which will be published next year, the government will look to identify specific barriers in access to healthcare and set out concrete action to remove them. Opinions from women who contributed to our 10 Year Health Plan consultation - the biggest ever conversation about the future of the NHS - will play a central role in developing this strategy. Health and Social Care Secretary Wes Streeting said: We inherited a broken NHS, and as a result too many women are still subject to a system that doesn’t listen to their experiences or understand their needs. Whether it’s being passed from one specialist to another for conditions like endometriosis or PCOS, the lack of proper pain relief during procedures, or unacceptable gynaecology waiting lists - it’s clear the system is failing women, and it shouldn’t be happening. Our renewed strategy will set out our longer-term vision so every woman gets the healthcare she deserves, when she needs it. We’re determined to build an NHS in which women can feel safe and can trust. Read press release Source: Department of Health and Social Care, 23 October 2025- Posted
-
- Womens health
- Health inequalities
- (and 3 more)
-
News Article
NHS health checks in England to have questions on menopause for first time
Patient Safety Learning posted a news article in News
NHS health checks are to include questions about the menopause for the first time, ministers have announced, with millions of women in England expected to benefit. Adults aged from 40 to 74 who do not have a pre-existing long-term health condition are eligible for an NHS health check every five years. The checks are intended to identify those at higher risk of heart and kidney disease, type 2 diabetes, dementia and stroke. The checks will also include questions about the menopause, which the Department of Health and Social Care (DHSC) estimates could help as many as 5 million women. The questions will be written over the next few months and ministers hope the change will take effect from 2026. The health secretary, Wes Streeting, said the change would give women “the visibility and support they have long been asking for.” “Women have been suffering in silence for far too long,” he said, and they are “left to navigate menopause alone, with very little support – all because of an outdated health system that fails to acknowledge how serious it can be. “No one should have to grit their teeth and just get on with what can be debilitating symptoms or be told that it’s simply part of life.” Read full story Source: The Guardian, 23 October 2025 Related reading on the hub: “It’s not menopause, you’re too young and don’t have the right symptoms"—the difficulties accessing menopause support and treatment -
News Article
Millions of women are being exploited by a “menopause gold rush” as companies, celebrities and influencers take advantage of a “dearth” of reliable information on the issue, experts have said. Healthcare companies and content creators saw menopause as a “lucrative market” and were trying to profit from gaps in public knowledge, women’s health academics at UCL said. Researchers called for the rollout of a national education programme after finding a significant number of women do not feel well-informed about menopause. Writing in medical journal Post Reproductive Health, they said: “There has been a rapid expansion in unregulated private companies and individuals providing menopause information and support for profit; this has been termed the ‘menopause gold rush’. “This fragmented landscape of menopause support and education leaves people vulnerable to financial exploitation, may propagate misinformation and is likely to amplify existing menopause-related health inequities.” One woman who took part in the UK study told researchers: “Everything I know about the menopause I learnt on Instagram from other women.” Only one in five – 22% – of 1,500 women surveyed by the UCL team felt well-informed about menopause. Read full story Source: The Guardian, 20 October 2025- Posted
-
- Menopause
- Communication problems
- (and 6 more)
-
News Article
Coroner expresses concerns over NHS menopause care after death of teacher
Patient Safety Learning posted a news article in News
A coroner has expressed wide-ranging concerns about how the NHS cares for women during menopause after the death of a 54-year-old teacher who killed herself after a decline in her mental health. Jacqueline Anne Potter took her own life during overnight leave from an acute psychiatric unit in Somerset where she was being looked after because of mental health issues exacerbated by menopause. In a prevention of future deaths report, senior coroner Samantha Marsh said she was concerned about the “lack of importance” given to menopausal care available on the NHS. She said: “Women who are not fortunate enough to be able to access private clinics and facilities may not be able to access the services and expertise they need at a very crucial transitional phase in their lives. Menopause is not a lifestyle choice, it is an unavoidable part of a woman’s natural biological cycle.” The coroner said: “Given her presentation it would appear that her underlying anxiety had been slowly building; possibly since 2008 but much more so since 2017.” She started HRT but in September 2022 declined again and the following month agreed to a voluntary admission to an acute psychiatric unit after she was found wandering in traffic. She was detained there under the Mental Health Act. Last month an inquest jury concluded that Potter’s death was suicide and said menopause “contributed to her mental health decline and exacerbated her underlying anxiety”. The jury also said that her family “did not receive appropriate information to assist them in keeping Anne safe for an overnight stay”. Read full story Source: The Guardian, 29 April 2025- Posted
-
- Coroner
- Coroner reports
-
(and 3 more)
Tagged with:
-
News Article
Therapy could be offered to women suffering menopause symptoms
Patient Safety Learning posted a news article in News
Women experiencing hot flushes, night sweats, depression and sleep problems could be offered therapy to help reduce their menopause symptoms, under new guidelines. But menopause champions warned that those suffering with symptoms could have long waits for mental health support and stressed that the new draft guidance to GPs from the National Institute for Health and Care Excellence (NICE) must not distract from “ongoing challenges” of getting HRT. A NICE evidence review found that cognitive behavioural therapy (CBT) can help make night-time sweats less severe and frequent and should be considered “alongside or as an alternative to HRT”. The guidance is not mandatory but GPs will be expected to take the new guidance “fully into account”, said Nice. Caroline Nokes, chair of the Commons’ women and equalities committee, welcomed the new guidance saying there was no “one size fits all” to help women going through the menopause, but said it must not be used to fob off women, some of whom were still facing drug shortages. A major HRT drug shortage last year resulted in 22 restrictions being put in place, pushing some women to turn to the hidden market or meet up with other women to buy, swap or share medicines. Read full story Source: The Guardian, 17 November 2023 -
News Article
Most women going through menopause are not receiving effective treatment for their symptoms, in part because of widespread misinformation, according to new research. A comprehensive literature review led by Prof Susan Davis from Monash University in Australia calls for more personalised treatment plans that address the greatly varying physical and mental symptoms of menopause. After adverse affects were reported from the landmark 2002 Women’s Health Initiative study into menopausal hormone therapy (MHT), Davis said there was a blanket fear that “hormones are dangerous” and as a result, “menopause [treatment] just went off the radar”. Read full story Source: The Guardian, 6 September 2023- Posted
-
- Menopause
- Womens health
- (and 4 more)
-
Content Article
This investigation by the Healthcare Safety Investigation Branch (HSIB) aimed to support improvements in the work of community mental health teams (CMHTs). Specifically, the investigation looked at the following four areas: assessing a patient’s risk of self-harm or suicide considering menopause as a risk factor for mental health conditions engaging with families caring for people with a first episode of psychosis. Reference event Ms A was 56 years old when she came into contact with mental health services for the first time in September 2019, following a suicide attempt. Ms A spent a month in hospital, and was then discharged home under the care of a community mental health team (CMHT) with a diagnosis of psychotic depression. At the end of May 2020, Ms A was again admitted to hospital following a second suicide attempt. She again stayed in the hospital for about four weeks before being discharged home under the care of a CMHT. Ms A was seen by CMHT workers regularly throughout July, and had a telephone review with a consultant psychiatrist. At the end of July, Ms A’s family became increasingly concerned about her mental state and were unable to make contact with her. On 2 August, Ms A was found deceased at home having died by suicide. Findings While national guidance says that a patient’s risk of harm should not be stratified into categories such as high, medium or low, such stratification remains common in many trusts. This is because other methods of assessing and documenting risk are not available, and because staff fear being blamed if a patient comes to harm without a risk assessment, including risk stratification, having been completed. Current research only demonstrates a link between menopause and low mood, and not between menopause and more severe mental health symptoms. Women are frequently prescribed antidepressant medication when hormone replacement therapy may be a more appropriate treatment for their symptoms. Menopause is not routinely considered as a contributing factor in women with low mood who are assessed by mental health services, and staff do not receive training in this area as standard. While there is a significant amount of national guidance relating to family engagement when treating patients with mental health conditions, mental health practitioners often find it difficult to know how and when to engage with families with complicated relationships or when the patient withdraws their consent for information sharing. There is a lack of training in this area to support staff with decision making. National guidance raised the upper age limit for referral to the Early Intervention in Psychosis pathway in 2016. Some trusts continue to prioritise younger patients for a variety of reasons – including funding, capacity and misconceptions about whether an older person can actually be experiencing a true first episode of psychosis in later life. Safety recommendations HSIB has made four safety recommendations as a result of this investigation. NHS England: HSIB recommends that NHS England works with appropriate stakeholders, including experts with appropriate experience, to create guidance on culture change. A quality improvement programme should also be developed to support practitioners in undertaking psychosocial assessments that are in line with guidance from the National Institute for Health and Care Excellence. Person-centred safety planning should be embedded within the process. Care Quality Commission (CQC): HSIB recommends that the Care Quality Commission evaluates the way in which it reviews how community mental health services assess risk of harm, to ensure its inspections are in line with the latest national guidance. National Institute for Health and Care Excellence (NICE): HSIB recommends that the National Institute for Health and Care Excellence evaluates the available research relating to the risks associated with menopause on mental health and if appropriate, updates existing guidance. Royal College of Psychiatrists (RCPsych): HSIB recommends that the Royal College of Psychiatrists forms a working group with relevant stakeholders to identify ways in which menopause can be considered during mental health assessments. Safety observations HSIB has made the following safety observations: It may be beneficial for mental health organisations to have a dedicated liaison officer who acts as a point of contact for both families and clinicians when navigating involvement in a patient’s care and decision making. It may be beneficial for organisations to involve families in care planning and assessments, and that practitioners are appropriately trained in working with families. It may be beneficial for education bodies to develop training programmes in safety planning and psychosocial assessments, once NHS England has provided guidance on how such assessments should be conducted. It may be beneficial for mental health organisations to ensure their Early Intervention in Psychosis referral process is in line with the national guidance, and that staff are clear about the upper age limit of patients accepted onto the pathway. Safety actions HSIB has noted the following safety action: NHS England has written to all mental health trusts in England to highlight the importance of taking a person-centred approach to psychosocial assessments and safety planning. The communication asks trusts to move away from risk assessment tools that stratify an individual’s risk of suicide or self-harm.- Posted
-
- Mental health
- Investigation
- (and 6 more)
-
News Article
Menopause is not a disease, say experts
Patient Safety Learning posted a news article in News
The menopause is not a disease and is being “over-medicalised”, experts have said. High-income countries, including the UK, commonly see menopause as a medical problem or hormone-deficiency disorder with long-term health risks “that are best managed by hormone replacement (therapy)”, they said. Yet, around the world, “most women navigate menopause without the need for medical treatments”, the experts, including from the Royal Women’s Hospital in Melbourne, Australia, and King’s College London, said. They argued there is a lack of data on whether health problems are caused by menopause or simply by ageing. In a first paper in The Lancet Series on the menopause, the experts said: “Although management of symptoms is important, a medicalised view of menopause can be disempowering for women, leading to over-treatment and overlooking potential positive effects, such as better mental health with age and freedom from menstruation, menstrual disorders, and contraception.” Series co-author Professor Martha Hickey, from the University of Melbourne and Royal Women’s Hospital, said: “The misconception of menopause as always being a medical issue which consistently heralds a decline in physical and mental health should be challenged across the whole of society. “Many women live rewarding lives during and after menopause, contributing to work, family life and the wider society. “Changing the narrative to view menopause as part of healthy ageing may better empower women to navigate this life stage and reduce fear and trepidation amongst those who have yet to experience it.” Read full story Source: The Independent, 5 March 2024- Posted
-
- Menopause
- Womens health
-
(and 2 more)
Tagged with:
-
Event
Everywoman festival
Patient Safety Learning posted an event in Community Calendar
untilThe Everywoman festival is a one day event aimed at all women over the age of 16 and aims to empower women to understand what is normal and when to seek help for issues that can affect 90% of women at some point in their life. The festival combines more than 40 workshops and 6 themed seminar sessions with a fun, relaxed environment with art workshops, food and drink, music and charity stands. Themes are wide ranging and include periods and endometriosis, pelvis pain and bladder, childbirth injury, menopause and sexual wellbeing. Additional drop in sessions to meet the consultant experts as well as book readings and signings will be available on the day. The Everywoman Festival will be held in the heart of Cardiff in the beautiful venue of Insole Court. It will feature a range of interactive workshops and talks from leading health experts. Attendees will have the opportunity to learn about everything from nutrition and fitness to mindfulness through art. For those who are looking for something a little more active, there will be a variety of fitness classes and workshops taking place throughout the day. From seated yoga, Pilates to Belly dancing and dancing lessons from Heels empowerment, there's something for everyone, regardless of their fitness level. Charities attending with stalls and information include Coppa feel, Endometriosis UK, Womens Aid, the Menstrual project and Fair Treatment for Women of Wales. Health stalls from Muslim Doctors Cymru, Medtronic, Mcgregor, THD will be on hand to provide information and signpost for everything from your bladder and bowels, childbirth to high blood pressure. Some of the highlights of the festival are the wellness market, where attendees can shop for a wide variety of health and wellness products and in the creative market products from artists such as Black and Beech, Melin Trygwynt and Eliza Eliza. Further tickets and information Follow on instagram @Theeverywomanfestival A5leaflet Everywoman (2).pdf- Posted
-
- Womens health
- Endometriosis
-
(and 3 more)
Tagged with:
-
News Article
New official guidance on treating menopause will harm women’s health, experts, MPs and campaigners have warned. Last month, new draft guidelines to GPs from the National Institute for Health and Care Excellence (NICE) said that women experiencing hot flushes, night sweats, depression and sleep problems could be offered cognitive behavioural therapy (CBT) “alongside or as an alternative to” hormone replacement therapy (HRT) to help reduce their menopause symptoms. But critics have castigated the guidance, saying it belittled symptoms through misogynistic language, and women’s health would suffer as a result of failing to emphasise the benefits of HRT on bone and cardiovascular health as opposed to CBT. In its response to the guidance, Mumsnet said NICE's recommendations used “patronising” and “offensive” language and would be “detrimental” to women’s health. Justine Roberts, the founder and chief executive of Mumsnet, said: “Women already struggle to access the HRT they are entitled to. We hear daily from women in perimenopause and menopause who are battling against a toxic combination of entrenched misogyny, misinformation and lack of knowledge among GPs. “Too often they are fobbed off or told they simply need to put up with severe physical and mental symptoms – often with life-changing effects. “By emphasising the negative over the positive, failing to include information about the safest forms of HRT and placing CBT on a par with hormone replacement therapy, this guidance will worsen that struggle. It will make doctors more reluctant to prescribe HRT and women more fearful about asking for or accepting it.” Carolyn Harris, the MP for Swansea East and the chair of the all-party parliamentary group on menopause, said the new guidance was “antiquated”, “naive” and “ill thought-out”. ”Talking can make you feel better, but it’s not going to take away the aches in your joints and it’s not going to change how you live your life,” she said. “Whatever a woman feels is what she needs to support her through the menopause should be readily and immediately available, and that’s not true currently [of HRT or CBT]." Read full story Source: The Guardian, 11 December 2023 -
Content Article
Many healthcare professionals are not trained in menopause care. The British Menopause Society (BMS) runs a training programme for healthcare professionals in the principles and practices of menopause care. The programme comprises progressive theory and practical training components designed to reflect modern NHS practice and meet the ever-increasing requirement for quality menopause education. The BMS Principles and Practice of Menopause Care course is for healthcare professionals seeking an in-depth and comprehensive grounding in menopause care. This course is suitable for doctors, nurses and pharmacists wishing to understand the essential foundations of menopause care The BMS Certificate in the Principles and Practice of Menopause Care for doctors and nurses who undertake menopause consultations in general practice, including NHS and private clinics. It is also suitable for pharmacists (clinical and independent prescribers). The BMS Advanced Certificate in the Principles and Practice of Menopause Care for doctors, independent nurse prescribers and pharmacist independent prescribers who wish to provide specialist menopause care, including management of complex cases. View the competency-based PPMC curriculum Apply now for a BMS PPMC course Apply now for the competency-based practical training- Posted
-
- Womens health
- Training
-
(and 1 more)
Tagged with:
-
News Article
Doctors warn against over-medicalising menopause after UK criticism
Patient Safety Learning posted a news article in News
Doctors have hit back at critics saying they are failing menopausal women, and said that treating menopause as a hormone deficiency that requires medical treatment could fuel negative expectations and make matters worse. Writing in the British Medical Journal they said there was an urgent need for a more realistic and balanced narrative which actively challenges the idea that menopause is synonymous with an inevitable decline in women’s health and wellbeing, and called for continued efforts to improve awareness about the symptoms and how to deal with them. “Menopause is a natural event for half of humankind. While media attention in the UK may give the impression that growing numbers of women are struggling to cope with menopausal symptoms and are seeking hormonal treatment, there is no universal experience and most women prefer not to take medication unless their symptoms are severe,” wrote Martha Hickey, a professor of obstetrics and gynaecology at the University of Melbourne, Australia, and colleagues. They added that over-medicalisation of the menopause risked collapsing this wide range of experiences into a narrowly defined disease requiring treatment. “It tends to emphasise the negative aspects of menopause and, while effective treatments are important for those with troublesome symptoms, medicalisation may increase women’s anxiety and apprehension about this natural life stage.” Women’s experiences of menopause were strongly influenced by personal, family and social factors, they said. For instance, a recent review found that negative attitudes and expectations before menopause predicted the likelihood of women experiencing distressing symptoms. “Changing the narrative by normalising menopause and emphasising positive or neutral aspects such as freedom from menstruation, pregnancy and contraception, together with information about managing troublesome symptoms might empower women to manage menopause with greater confidence,” Hickey said. Read full story Source: The Guardian, 15 June 2022 -
News Article
Home menopause tests are waste of time and money, say doctors
Patient Safety Learning posted a news article in News
Women are wasting their time and money buying do-at-home menopause testing kits, doctors have warned. The urine tests are not predictive enough to tell whether a woman is going through the phase when her periods will stop, doctors have told the BBC. The tests, which give a result within minutes, accurately measure levels of follicle-stimulating hormone (FSH), which helps manage the menstrual cycle. But experts say it is not a reliable marker of the menopause or perimenopause. Dr Annice Mukherjee, a leading menopause and hormone doctor from the Society of Endocrinology, told the BBC the FSH urine tests were “another example of exploitation of midlife women by the commercial menopause industry, who have financial conflicts of interest”. “It’s not helpful for women to access [FSH] directly,” she said. “It is not a reliable marker of perimenopause and can cause more confusion among women taking the test. At worst, misinterpretation of results can cause harm.” The Royal College of Obstetricians and Gynaecologists (RCOG), along with other leading experts in women’s health, said the tests could be unhelpful and potentially misleading. Read full story Source: The Guardian, 10 June 2022- Posted
-
- Menopause
- Womens health
-
(and 3 more)
Tagged with:
-
Content Article
HSJ hosts the Patient Safety Watch newsletter, written by Patient Safety Watch chief executive James Titcombe. -
Content Article
Jacqueline Anne Potter, known as Anne, was a 54 year old teacher who died by suicide following a decline in her mental health. Anne died during overnight leave from an acute psychiatric unit in Somerset, where she was being looked after because of mental health issues exacerbated by menopause. In this report, the coroner raises concerns about her care and the lack of importance given to menopausal care in the NHS. Coroner's matters of concern Overnight leave arrangements When Anne was sent on her first overnight leave there was no codified ‘risk’ and ‘safety planning’ document. While in Anne’s case the report notes that it was widely accepted that her husband was well versed and knowledgeable about his wife’s risks and the measures that might be necessary to help keep her safe whilst she was at home, the Coroner noted that this may not apply in other cases. The report said that whilst families are not mental health practitioners and are not expected to adopt that role within the community there appears to be an opportunity to supply families with a short, codified document dealing with salient points of risks and safety planning when a patient goes for their first overnight leave since being detained. The Coroner suggests that this could help equip families with the knowledge to spot signs of declining mental presentation and/or risk and provide them with the knowledge and/or tools to take appropriate steps to assist in safeguarding their loved ones while they are in the community. Internet access in mental health settings The report notes that it found that if an in-patient (detained or voluntary) accesses the secure unit Wi-Fi there are no algorithms or ‘search detection features’ to prevent access to websites pertaining to self harm and so these can be readily accessed by a group who are already vulnerable due to their acute mental health presentation with some element of inherent risk of suicide. The Coroner noted that workplace organisations do have the ability to block sites if they deem it undesirable for their workforce to access (such as sites relating to gambling, sexually inappropriate content, etc). The report states that by allowing an already vulnerable group to have unfettered access to websites dedicated to self harm creates a risk of further deaths. Menopausal care The Coroner noted several areas of concern about menopausal care available on the NHS: Menopausal training is not mandatory in any area of clinical practice or specialism. The Coroner expressed concerns that there is no requirement to undertake essential compulsory menopausal training for those working in ‘relevant’ clinical practices such as mental health practice, obstetrics and gynaecology, and oncology, or even general as a general GP. The Coroner noted that she was told that the Trust has just one ‘menopause specialist’ (a GP) who covers the entire Trust operations. Not all GP surgeries have a menopause specialist practitioner (or access to one) despite a GP usually being the first port of call for women in the community when seeking primary care. Those GP surgeries who do have a practitioner who acts as a ‘specialist’ is often a GP with a personal interest who has taken the initiative to go on courses and broaden their learning and understanding, rather than any mandatory requirement for a surgery [or group with multiple surgeries] to have an available community ‘front-line’ specialist. She also noted that: “I was told during a previous PFD Response relating to menopausal knowledge and care within the NHS that “It is important to ensure that women understand common symptoms such as anxiety, stress and depression which they might experience during the menopause and where and when to seek help. The NHS website has resources….” This emphasises my concerns entirely; the lack of importance given to menopausal symptoms. If someone has concerns about heart disease, a worrying lump, a broken bone etc they expect to be able to consult a medically qualified professional who has a knowledge and understanding of their condition or presentation and can diagnose and treat accordingly; not just [and I paraphrase] ‘have a look at a website to help’.” Concluding, the Coroner referenced being told in a response to a previous Prevention of Future Deaths report where she raised similar concerns about a roll-out of specialist menopausal care and upskilling of GPs. She stated that from reviewing this case there was little evidence that this has happened/is happening and said that women continue to approach and navigate the menopause without the support of expert clinicians or practitioners who understand and can treat the symptoms they are experiencing.- Posted
-
- Patient death
- Mental health
-
(and 3 more)
Tagged with:
-
Content Article
Safety For All: 2023 Conference report
Patient Safety Learning posted an article in Improving patient safety
The second annual Safety For All conference was held at the Royal College of Physicians in London on Tuesday 5th December 2023. Over 100 members of the healthcare community attended this event, including occupational health professionals, patient safety experts, frontline staff, patients and academics. The conference was hosted by the Safer Healthcare and Biosafety Network and Patient Safety Learning as part of the Safety For All campaign, supported by B. Braun, BD, Boston Scientific and Stryker. Attendees had the opportunity to hear from two keynote speakers: Lynn Woolsey, UK Deputy Chief Nurse at the Royal College of Nursing and Dr Henrietta Hughes, Patient Safety Commissioner for England. The conference was chaired and facilitated by Dr Rob Galloway, A&E Consultant at Brighton and Sussex Hospital NHS Trust, with a welcome introduction from Dr Ian Bullock, CEO of the Royal College of Physicians. There were a number of panel sessions and presentations throughout the day which are summarised in the attachment below, including on sustainability, antimicrobial resistance and antibiotic underdosing, violence at work, clinical communications, human factors, implementing the Patient Safety Incident Response Framework (PSIRF), and women's health and the menopause.- Posted
-
- Patient engagement
- Sustainability
- (and 8 more)
-
News Article
‘I developed ovarian cancer after my symptoms were dismissed as menopause’
Patient Safety Learning posted a news article in News
A woman has said her ovarian cancer diagnosis was delayed after her symptoms were wrongly dismissed as menopause or irritable bowel syndrome (IBS) – accusing her doctor of misogyny and medically gaslighting her. Sbba Siddique, a 55-year-old business owner, told The Independent that “unconscious bias and cultural incompetence” were also to blame for her delayed diagnosis. Ms Siddique, who lives in Berkshire, said she began to feel unwell around October 2021 but did not get diagnosed with late-stage ovarian cancer until March the following year. “I was feeling really tired all the time. I had no energy. I was piling on weight that wasn’t there previously despite not changing my eating habits. I was needing to wee more,” the mother of three recalled. “I was going back and forth with my GP trying to get an appointment. I couldn’t get a face-to-face – every consultation was on the phone or via online forms. That was part of the problem of the misdiagnosis.” Her GP was “very dismissive” of her symptoms and attributed them to IBS or the menopause, she added. “At the end of the day, I’m not the expert, the GP is – I believed him,” she said. Read full story Source: The Independent, 14 July 2024 -
News Article
Hopes for changes in surgical menopause care
Patient_Safety_Learning posted a news article in News
Hundreds of women who are "plunged into surgical menopause" are "being failed by the NHS", says a menopause support campaigner. Diane Danzebrink, 58, from Norfolk, has called for an urgent review of surgical menopause care to ensure all clinicians know how to prepare their patients. Ms Danzebrink, who founded Menopause Support, said awareness had improved significantly, but "we haven't seen change fundamentally to ensure every woman has access to good quality care at the time that she needs it". Read full story Source: BBC, 28 December 2024- Posted
-
- Womens health
- Menopause
-
(and 1 more)
Tagged with:
-
News Article
HRT should be offered as first-line treatment for menopause, says Nice
Patient Safety Learning posted a news article in News
Women with menopause symptoms should be offered hormone replacement therapy (HRT) as a first-line treatment, not therapy, according to the National Institute for Health and Care Excellence (Nice). Its final menopause guidelines for medics in England and Wales, published on Thursday, state that HRT is the preferred treatment for managing symptoms such as hot flushes, night sweats, depression and sleep problems, in what is seen as a climbdown from previous wording. Controversial draft guidance published last November said women experiencing these menopausal symptoms could be offered cognitive behavioural therapy (CBT) “alongside or as an alternative to” HRT. The draft guidance provoked widespread criticism that it put CBT on a par with HRT, thereby belittling symptoms and harming women’s health. Nice said it has responded to the feedback and rewritten the guidelines, which now say CBT should only be considered for patients on HRT who still have symptoms, or those who are unable or do not wish to take HRT. Prof Jonathan Benger, chief medical officer and interim director of the centre for guidelines at Nice, said: “We are not suggesting that CBT is an alternative to HRT. It’s not an either/or, and we have worked through the guidelines extensively to really clarify this point. “We are very keen to emphasise that HRT is our recommended first-line therapy for vasomotor symptoms [night sweats and hot flushes] and for [other] symptoms of menopause.” Read full story Source: The Guardian, 7 November 2024- Posted
-
- Medication
- Menopause
-
(and 1 more)
Tagged with: